Schott Pharma AG & CO KGaA (1SXP)
TG
Year End September 29 2023 | 2023 |
---|---|
EUR (€) | |
Total Revenue | 898.6M |
Operating Income | 189.28M |
Pre Tax Income | 185.8M |
Net Income | 151.84M |
Preferred Dividends | 0 |
Basic Earnings Per Share (EPS) | 1.008 |
EBIT | 189.67M |
EBITDA | 241.12M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.